Intel stock extends gains after report of possible U.S. government stake
Fortrea Holdings (FTRE) stock has plummeted to $6.36, near its 52-week low of $6.73, representing an 82% decline over the past year. According to InvestingPro analysis, the stock’s RSI indicates oversold territory, while management has been actively buying back shares. This significant drop reflects a tumultuous period for the $612 million market cap firm, with investors showing concern over its performance. Despite current challenges, InvestingPro data suggests the company is undervalued, with analyst price targets ranging from $9 to $15.50, and net income expected to grow this year. For deeper insights, access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers, covering this and 1,400+ other US stocks.
In other recent news, Fortrea Holdings has reported lower-than-expected earnings and revenue for the fourth quarter, with an EPS of $0.18, falling short of the analyst estimate of $0.42. The company also saw a decrease in quarterly revenue to $697 million, compared to the expected $813 million. Fortrea’s full-year guidance for 2025 anticipates revenues between $2.45 billion and $2.55 billion, below the consensus estimate of $2.74 billion. Fitch Ratings has downgraded Fortrea’s credit rating due to a weakening credit profile, predicting a 7.3% decline in revenues for 2025, with a return to growth expected in 2026. Additionally, TD Cowen and Citi have both reduced their price targets for Fortrea, to $11 and $12, respectively, maintaining a Hold and Neutral rating on the stock. These adjustments follow Fortrea’s recent earnings call and reflect ongoing challenges in its financial performance. In a strategic move, Fortrea has appointed Erin L. Russell as a new director, bringing her extensive experience in finance and healthcare to the board. These developments indicate a challenging period for Fortrea as it navigates the evolving landscape of the CRO industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.